Abstract:Colorectal cancer is a most frequent type of gastrointestinal tract cancers. The prognosis of patients with colorectal cancer remains poor despite intensive interventions. Tumor specific promoter-directed gene therapy and adenoviral technology can be promising strategies for such advanced disease. This study was conducted to explore the possible therapeutic approach of Cox-2 promoter-directed suicide gene therapy with herpes simplex virus thymidine kinase (HSV-tk) in combination with adenoviral technology for advanced colorectal cancer. Firstly, the activity of Cox-2 promoter was assessed by dual luciferase and enhanced green fluorescent protein reporter gene assays in colorectal cancer cell lines and normal human intestinal epithelial cell line. Then, the expression of coxsackievirus and adenovirus receptor (CAR) was detected in colorectal cancer cell lines. The Cox-2 promoter-directed HSV-tk/ganciclovir (GCV) system mediated by adenovirus (Ad-Cp-TK) was developed (Ad-CMVp-TK, Ad-null and no Ad as controls). In vitro cytoxicity, colony formation and apoptosis assays were performed using Ad-Cp-TK. An animal study was carried out in which BALB/C nude mice bearing tumors were treated with Ad-Cp-TK and GCV treatments. Results showed that Cox-2 promoter possessed high transcriptional activity in a tumor-specific manner. All colorectal cancer cells were detected CAR-positive. In vitro cytotoxic and colony formation assays showed that colorectal cancer cells infected with Ad-Cp-TK became more sensitive to GCV but the sensitivity of normal cells infected with Ad-Cp-TK to GCV were not altered. Moreover, the Ad-Cp-TK system combined with GCV treatment could significantly induce apoptosis of colorectal cancer cells but not normal intestinal epithelial cells. Furthermore, this system also significantly inhibited the growth of subcutaneous tumors and prolonged survival of mice. Thus, adenovirus primary receptor was positive in colorectal cancer cells and adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter could provide a promising treatment modality for advanced colorectal cancer with tumor specificity.

Gene Therapy for Colorectal Cancer by an Oncolytic Adenovirus That Targets Loss of the Insulin-Like Growth Factor 2 Imprinting System

Gene Therapy for Human Colorectal Cancer Cell Lines with Recombinant Adenovirus 5 Based on Loss of the Insulin-Like Growth Factor 2 Imprinting.

Targeted tumor gene therapy based on loss of IGF2 imprinting.

Gene Therapy for Cancer Through Adenovirus Vector-Mediated Expression of the Ad5 Early Region Gene 1A Based on Loss of IGF2 Imprinting

Gene Therapy For Colorectal Cancer By Adenovirus-Mediated Sirna Targeting Cd147 Based On Loss Of The Igf2 Imprinting System

Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

Targeted therapy for malignant cancer mediated by adenovirus vector expressing diphtheria toxin a based on loss of IGF2 imprinting

[Effect of Recombinant Adenovirus Ad-DT-A in Targeted Therapy for Malignant Cancer Cell Lines with Loss of IGF2 Imprinting].

Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation.

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Menstrual Blood-Derived Stem Cells As Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer

Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line

Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering Rna

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer

GFP Plasmid and Chemoreagent Conjugated with Graphene Quantum Dots as a Novel Gene Delivery Platform for Colon Cancer Inhibition In Vitro and In Vivo

Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model

Construction and identification of recombinant adenovirus carrying IGF2 imprinting system

Potent And Specific Antitumor Effect For Colorectal Cancer By Cea And Rb Double Regulated Oncolytic Adenovirus Harboring St13 Gene

Oncolytic Adenovirus Programmed by Synthetic Gene Circuit for Cancer Immunotherapy